Brazilian antitrust watchdog CADE has blocked a deal announced by healthcare company Hapvida Participações to by health insurer Plamed.
CADE´s technical body had given an earlier approval to the deal demanding the sale of part of its 26,000 clients portfolio, but the councillors voted to bar the deal completely. In a securities filing late on Wednesday, the company said it was discussing with its advisors the alternatives for the deal.
Copyright © 2024 M&A Critique!. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.We have made a sincere effort to ensure that all photographs used on this website are either freely available in the public domain or used with permission. If you believe your work is being used inappropriately, please let us know and we will address the matter immediately.
[ultimatemember form_id=140]
WhatsApp us